z-logo
open-access-imgOpen Access
Professionals’ Treatment Preferences in the Prodromal Phase of Parkinson’s Disease: A Discrete Choice Experiment
Author(s) -
Lieneke van den Heuvel,
Wibe Hoefsloot,
Bart Post,
Marjan J. Meinders,
Bastiaan R. Bloem,
Anne M. Stiggelbout,
Janine A. van Til
Publication year - 2022
Publication title -
journal of parkinson s disease
Language(s) - English
Resource type - Journals
eISSN - 1877-718X
pISSN - 1877-7171
DOI - 10.3233/jpd-223208
Subject(s) - disease , neurology , health professionals , parkinson's disease , medicine , prodromal stage , expectancy theory , life expectancy , psychology , clinical psychology , psychiatry , health care , dementia , population , social psychology , environmental health , economics , economic growth
In Parkinson's disease (PD), several disease-modifying treatments are being tested in (pre-)clinical trials. To successfully implement such treatments, it is important to have insight into factors influencing the professionals' decision to start disease-modifying treatments in persons who are in the prodromal stage of PD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom